SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 74 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $27,577,000 | +43.3% | 1,536,333 | -5.8% | 0.00% | 0.0% |
| Q3 2017 | $19,250,000 | +11.4% | 1,631,413 | -0.9% | 0.00% | 0.0% |
| Q2 2017 | $17,287,000 | +7.9% | 1,646,348 | +13.0% | 0.00% | 0.0% |
| Q1 2017 | $16,024,000 | +20.9% | 1,456,787 | +48.9% | 0.00% | 0.0% |
| Q4 2016 | $13,259,000 | +11.1% | 978,561 | +1.0% | 0.00% | 0.0% |
| Q3 2016 | $11,932,000 | -6.9% | 969,222 | -17.0% | 0.00% | 0.0% |
| Q2 2016 | $12,817,000 | -39.6% | 1,168,415 | -39.8% | 0.00% | 0.0% |
| Q1 2016 | $21,211,000 | -37.1% | 1,940,612 | -0.4% | 0.00% | -50.0% |
| Q4 2015 | $33,704,000 | +1.7% | 1,949,288 | +16.9% | 0.00% | +100.0% |
| Q3 2015 | $33,139,000 | +115.8% | 1,667,772 | +78.5% | 0.00% | 0.0% |
| Q2 2015 | $15,354,000 | +41.4% | 934,493 | +33.9% | 0.00% | 0.0% |
| Q1 2015 | $10,859,000 | +33.0% | 697,838 | +22.1% | 0.00% | 0.0% |
| Q4 2014 | $8,164,000 | +100.3% | 571,764 | -8.8% | 0.00% | – |
| Q3 2014 | $4,075,000 | -4.2% | 627,001 | +1.8% | 0.00% | – |
| Q2 2014 | $4,252,000 | +8.1% | 616,217 | +12.0% | 0.00% | – |
| Q1 2014 | $3,934,000 | -15.8% | 550,094 | +10.6% | 0.00% | – |
| Q4 2013 | $4,674,000 | +37.4% | 497,317 | -8.8% | 0.00% | – |
| Q3 2013 | $3,402,000 | -8.9% | 545,126 | -4.0% | 0.00% | – |
| Q2 2013 | $3,734,000 | – | 567,577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|